October 18, 2023
After a series of startling kickback cases, Novartis Pharmaceuticals on Wednesday contrasted its past misdeeds with newer accusations it bribed prescribers, and Second Circuit judges seemed sympathetic as they pressured a whistleblower's lawyer to substantiate a supposed nationwide scheme.
April 28, 2023
Novartis is arguing that the Second Circuit should not revive a former sales rep's suit claiming the company bribed doctors across the country, saying the lower court rightly found that its conduct was above board.
January 27, 2023
A former Novartis Pharmaceuticals sales rep has asked the Second Circuit to restore his whistleblower lawsuit alleging the company bribed doctors nationwide, arguing that the lower court's "deeply flawed analysis" last year gave too much deference to the defendant.